Digital therapeutics for migraine and headache
From clinical trials to market: Cenli® available in Norway
Cenli® brings science-backed biofeedback training into your home — no clinic or appointments needed. With just a few minutes a day, you can train your nervous system to find calm, improve focus, and build resilience. Backed by research on biofeedback and nervous system regulation.
Buy Cenli
Our solutions
The problem
Migraine, affecting 14% worldwide, is the leading cause of disability for young women globally
and ranks second across all genders. Its widespread yet underdiagnosed presence, with only half seeking treatment, underscores a crucial unmet medical need and a significant societal burden.
News
BiofeedbackSeptember 02, 2026BioCer randomized controlled trial published in Cephalalgia
The results of the BioCer randomized controlled trial have been published in Cephalalgia, the journal of the International Headache Society.
MigraineMarch 07, 2026The 2025 Landscape of Digital Headache Technology: A Summary of Dr. Anker Stubberud’s Latest Insights
BiofeedbackFebruary 17, 2026Multicenter Study on Tension-Type Headache Underway
A major multicenter clinical study investigating biofeedback for tension-type headache has now begun across several Norwegian hospitals. Below, we share key details about the BioTenCer study and our role as technology provider.
Migraine is one of the most disabling diseases worldwide
The right tools can empower patients to understand their condition and regain control. Brain Twin is such an app. The app is user-friendly and includes a dark mode option for users with light sensitivity.
Explore Brain Twin
